The T-box containing Tbr2 gene encodes for a transcription factor essential for the specification of the intermediate neural progenitors (INPs) originating the excitatory neurons of the cerebral cortex. However, its overall mechanism of action, direct target genes and cofactors remain unknown. Herein, we carried out global gene expression profiling combined with genome-wide binding site identification to determine the molecular pathways regulated by TBR2 in INPs. This analysis led to the identification of novel protein-protein interactions that control multiple features of INPs including cell-type identity, morphology, proliferation and migration dynamics. In particular, NEUROG2 and JMJD3 were found to associate with TBR2 revealing unexplored TBR2-dependent mechanisms. These interactions can explain, at least in part, the role of this transcription factor in the implementation of the molecular program controlling developmental milestones during corticogenesis. These data identify TBR2 as a major determinant of the INP-specific traits by regulating both genetic and epigenetic pathways.
Introduction
The mammalian cerebral cortex is a complex ensemble of several neuronal and glial subtypes that are radially arranged in six layers and tangentially organized in several operational domains. Excitatory principal neurons are the largest neuronal population in the cerebral cortex that arise during development in a stereotyped temporal order from a population of neuronal progenitors known as radial glial cells (RGCs).
Neurogenesis has a bimodal behavior in the developing cortex, presenting a direct or indirect process, which depends by the presence or not of a second class of neural progenitors called intermediate (or basal) neural progenitors (INPs) (Noctor et al. 2004; Götz and Huttner 2005) . During direct neurogenesis, one RGC divides asymmetrically to produce a daughter RGC and a neuron, while in the indirect process, the RGC generates one INP that moves into the subventricular zone (SVZ) where it divides symmetrically one or few more times before differentiating into neurons.
Neural stem cells (NSCs) maintain features of RGCs when cultured in vitro and have enabled the dissection of the molecular events that regulate RGC identity, self-renewal and proliferation dynamics (Muzio et al. 2002; Konno et al. 2008; Asami et al. 2011; Postiglione et al. 2011) . In contrast, little is known on the genetic components regulating the INPs that lack a corresponding in vitro cell counterpart (Conti and Cattaneo 2010) .
The transcription factor Tbr2 (NCBI: Eomes) is one of the major intrinsic determinants of the INPs (Noctor et al. 2004; Hevner et al. 2006) . In fact, others and we have described its essential role in INP identity during cortical and hippocampal development using loss-and gain-of-function approaches (Arnold et al. 2008; Sessa et al. 2008 Sessa et al. , 2010 Hodge et al. 2012; Kahoud et al. 2014) . Importantly, Tbr2 inactivation leads to an important decrease in the INP number and, in turn, in the final number of excitatory neurons in the cerebral cortex. These findings are consistent with the microcephalic manifestations occurring in patients with a TBR2 gene deletion (Baala et al. 2007) . Recently, in vivo tracing of the Tbr2+ NPC lineage revealed that virtually all cortical glutammatergic neurons transit through a Tbr2+ intermediate state during their development (Vasistha et al. 2015) , confirming previous observations in Tbr2 mutant mice (Pontious et al. 2008; Sessa et al. 2008; Kowalczyk et al. 2009 ). Together with the RGCs located far from the ventricle (outer or basal RGCs), TBR2+ INPs are the major cellular component of the recently characterized outer subventricular zone (OSVZ), a morphological hallmark of girencephalic cortices as those of primates and humans (Fietz et al. 2010; Hansen et al. 2010; Reillo et al. 2011; Reillo and Borrell 2012; Florio et al. 2015) . Beyond the leading role of the outer RGCs in promoting cortical foldings, the concomitant increase in TBR2+ INPs and their heightened proliferation potential might indicate a significant contribution of these cells in the evolutive cortical expansion (Martínez-Cerdeño et al. 2016) . Accordingly, increasing number of TBR2+ INPs leads in mice to a significant enlarged cortical surface area, while in ferrets in the formation of additional folds and fissures (Nonaka-Kinoshita et al. 2013) . In addition, a large scale transcripto mic study in gyrencephalic species highlighted the relevance for Tbr2 in the OSVZ for promoting and sustaining cerebral cortical expansion and folding (de Juan Romero et al. 2015) .
Despite the increasing role of INPs in cortical development and evolution, the understanding of the Tbr2 molecular network has remained limited . Herein, we sought to undertake a genomic approach to decipher the TBR2 dependent molecular mechanisms controlling both morphological and functional features of INPs. To this end, we generated and cross-referenced datasets of the Tbr2-dependent expression profiling and its genomic binding profile. Through this systematic survey, we identified numerous Tbr2 target genes, which have a role in shaping the morphology and behavior of INPs from their genesis to long-term maintenance. Importantly, we revealed that TBR2 exerts its functions in either controlling the expression of target genes directly or modulating the action of other regulatory proteins. In fact, we identified its cooperation with the proneural transcription factor NEUROG2 and the histone demethylase JMJD3 (NCBI: KDM6B). In particular, TBR2 directs JMJD3-dependent chromatin remodeling to specific genomic targets to enable the removal of H3K27me3 chromatin mark. Altogether, this genomic analysis reveals the complex molecular program regulated by TBR2 for the correct establishment of the cortical neuronal differentiation process through both genetic and epigenetic mechanisms.
Materials and Methods

Animals
Tbr2 conditional mutant mice (Tbr2flox/flox, Tbr2 cKO) were maintained by backcrossing with C57Bl/6 animals. To inactivate Tbr2 in the developing forebrain, Tbr2flox/ flox mice were crossed with Tbr2flox/+; Foxg1-Cre animals (Hébert and McConnell 2000) . Genotyping was performed as described previously to distinguish wild-type, floxed, and deleted Tbr2 alleles ). Mice were maintained at the San Raffaele Scientific Institute Institutional mouse facility, and experiments were performed in accordance with experimental protocols approved by local Institutional Animal Care and Use Committees (IACUC).
RNA Isolation, Processing and Microarray Analysis
E14.5 embryos from Tbr2flox/flox × Tbr2flox/+; Foxg1-Cre were harvested and placed into cold PBS. After brain isolation, meninges and olfactory bulbs were removed, and the cerebral cortex separated from the ventral telencephalon. The same procedure was repeated for 3 control (Tbr2flox/+; Foxg1-Cre) and 3 Tbr2 mutant (Tbr2flox/flox; Foxg1-Cre) embryos. Total RNA was extracted from the tissues by using the Qiagen RNA micro kit (Qiagen, Valencia, CA) and cRNAs generated and hybridized on a total of six different MOE430v2 Affymetrix DNA chips according to the Affymetrix protocol. The chips were scanned (Affymetrix) to generate digitized image data files. The data were deposited in the NCBI Gene Expression Omnibus (Edgar et al. 2002) and are accessible through GSE63621.
Microarray Data Analysis
Microarray quality control and statistical validation were performed using Bioconductor (Gentleman et al. 2004; Sanges et al. 2007) . Background correction, normalization, and probe set intensities were obtained by means of GCRMA (Wu and Irizarry 2004) . To assess differential expression we performed twosample t-test to rank differentially expressed genes between Tbr2 mutants and controls. We compensate multiple testing and compute false discovery rate (FDR) using beta-uniform mixture model (BUM) (Pounds and Morris 2003) . Gene Ontology (GO) analysis was performed using DAVID (http://david.abcc. ncifcrf.gov) (Huang et al. 2009 ).
Quantitative Real-Time PCR and Quantification
About 2 μg of the total RNA extracted from Ctrl and Tbr2 mutant dorsal telencephali were reverse transcribed with random hexamers as primers using a Thermoscript RetroTranscriptase (Invitrogen). Oligonucleotide primers for the amplification of the selected genes are reported in Table S3 . qPCRs were carried out in a final volume of 25 μl, containing a concentration of 100 nM of each primer, 1× Syber Green supermix (Biorad) and 2 μl of the RT products. Thermal cycling was performed using a Mx3005 P QPCR system (Stratagene). Melting curve analysis was performed for each reaction to ensure a single peak and amplicons were visualized after electrophoresis on a 2% agarose gel to ensure the presence of a single PCR product.
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The Livak method was applied for quantification (Schmittgen and Livak 2008) . Briefly, the expression of each gene either in wild-type or in mutant samples was normalized to that of the housekeeping gene β-actin: to this purpose a ΔCT, WT = (CT, gene -CT, act )WT and a ΔCT, MUT = (CT, gene -CT, act)MUT were calculated for each amplified gene and results reported as fold change (2-ΔΔCT) in gene expression of Tbr2 mutant samples relative to the wild-type, where -ΔΔCT = -(ΔCT, MUT -ΔCT,WT). The data were plotted as means of at least three animals per genotype (biological replicates) and three independent amplifications (technical replicates). Error bars represent standard error of the mean.
In Situ RNA Hybridization
ISHs on frozen sections were performed as previously described by Schaeren-Wiemers and Gerfin-Moser (1993) with the following modifications. Sections were fixed for 30 min at room temperature in 4% paraformaldeyde in PBS and treated for 5 min with 1 µg/ml proteinase K in 1 mM EDTA, 20 mM Tris-Hcl (pH7.0). Prior to hybridization, they were washed twice in 2× SSC for 15 min, and incubated in 0.1 M Tris/0.1 M of glycine for at least 30 min. The hybridization solution (60 µl/slide) contained 50% formamide, 5× SSC (pH adjusted with citric acid to pH6.0), 5% dextran sulfate, 2 mg/ml heparin, 100 µg/ml tRNA and from 1:100 to 1:50 dilution of the riboprobes, and was performed overnight at 65°C using coverslips. Next, the sections were washed for 1-2 h in 0.5× SSC, 20% formamide at 65°C. Subsequently, they were treated with 10 µg/ml RNaseA for 30 min at 37°C in NTE, then washed for 4 h in 0.5× SSC, 20% formamide a 65°C and for 30 min in 2× SSC, and blocked for 1 h at room temperature in 1% blocking reagent (Roche, Switzerland) in MABT. A 1:5000 dilution of anti-digoxigenin-AP conjugated antibody (Roche) was preincubated for at least 1 h in 1% blocking reagent in MABT at 4°C. Slices were incubated with the antibody overnight at 4°C, washed for 6 h in TBST, for 30 min in NTMT, and stained using centrifuged BM purple AP substrate (Roche) in 0.3% Tween-20 for 12-36 h at 4°C or room temperature. Slices were washed in NTMT, then in distilled water, and mounted in Aquamount (Polysciences). The following probes were used: Ebf1, Ebf2, Ebf3 (kindly provided by Dr Giacomo Consalez), Gbx2, Rnd2, Jmjd3, Sox5, Tle4, Math2.
Chromatin Immunoprecipitation
E14.5 cortices (dissected in cold HBSS) or NSCs were fixed 45' in PBS containing 2 mM di-succinimidyl-glutarate (DSG). After washing with PBS, protein-DNA interactions were fixed by 10 min incubation in 1% formaldehyde at room temperature. Crosslinking was then quenched by addition of glycine to a final concentration of 125 mM Glycin. Subsequently, cells were washed in PBS, harvested by scraping, and resuspended in SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris), containing protease inhibitors (Roche). The chromatin was sheared by sonication using a Bioruptor (Diagenode) sonicator for 25-30 min in 30 s ON/OFF cycles. Samples were centrifuged at 1600 × g to remove debris and the DNA-concentration was determined using a Nanodrop Spectrophotometer. Immunoprecipitations with mouse anti-Tbr2 (AbCam #ab23345), anti-Neurog2 (generous gift of Yong Chao Ma and Mike Greenberg) or control GFP antibodies (Molecular Probes #6455) were done as described ) using 80 µg of chromatin and 2 µg of antibody per assay. DNA sequences were quantified by real-time PCR (primers are listed in Table S3 ). Quantities of immunoprecipitated DNA were calculated by comparison with a standard curve generated by serial dilutions of input DNA. The data were plotted as means of at least two independent ChIP assays (biological replicates) and three independent amplifications (technical replicates). Error bars represent standard error of the mean.
ChIP-sequencing
Tbr2 and Neurog2 ChIP samples were sequenced with Illumina Genome Analyzer IIx. ChIP-seq data analysis was performed with the GeneProf web-based software (Halbritter et al. 2012 (Halbritter et al. , 2014 . Sequences with a Mean Quality Score > 10 were aligned to the mm9 reference genome with Bowtie v0.12.3. ChIP peaks were called with MACS v1.4 (Bandwidth = 200; FDR < 0.1) and adjusted with the dynamic λ calculation to account for the potential local bias imposed by chromatin structure. Tracks were displayed on the reference genome with the IGV software (Thorvaldsdóttir et al. 2013) . Statistical enrichments for associations between genomic regions and functional annotations were performed with GREAT (McLean et al. 2010 ). The GEO accession number for the ChIP-seq data reported in this paper is GSE63621.
In Utero Electroporation
Electroporation in utero was employed to deliver expression vectors to the ventricular RGCs of mouse embryos as previously described (Gal et al. 2006; Saito 2006) . Briefly, uterine horns of E12.5 or E13.5 pregnant dams were exposed by midline laparotomy after anesthetization with Avertin (312 mg/kg). One microliter of DNA plasmid corresponding to 3 µg mixed with 0.03% fast-green dye in PBS was injected in the telencephalic vesicle using a pulled micropipette through the uterine wall and amniotic sac. Platinum tweezer-style electrodes of 7mm were placed outside the uterus over the telencephalon and 5 pulses of 40 V, 50 ms in length, were applied at 950 ms intervals by using a BTX square wave electroporator. The uterus was then replaced in the abdomen, the cavity was filled with warm sterile PBS and the abdominal muscle and skin incisions were closed with silk sutures.
Organotypic Culture and Focal Electroporation
E14.5 embryonic mouse midbrain were isolated, embedded in 4% low-melting agarose (Sigma) and 250 µm thick coronal sections were cut using a vibratome (VT1100, Leica). The sections were then transferred to polycarbonate culture membranes (diameter, 13 mm; pore size 8 µm; Costar) in organ tissue dishes containing 1.5 ml of serum-containing medium (Gibco a-MEM with 10% fetal calf serum, glutamine, penicillin and streptomycin). Slices were maintained for 1 h at 37°C in 5% CO 2 in a standard sterile incubator. Before changing to the Neurobasal/B27 (Gibco) medium, 1 µl of DNA plasmid corresponding to 5 µg mixed with 0.03% fast-green dye in PBS was mouth-injected in the area of interest and the same area was electoporated with a square-electroporator (ECM830, BTX, Holliston, MA) using planar electoctodes (BTX) and applying 2 electric pulses of 100 V for 5ms as described by Stühmer et al. (2002) . Organotypic slices were maintained for 2 days in vitro and then fixed in 4% PFA in PBS, cryoprotected in 30% sucrose, embedded in OCT coumpond, and resectioned on a cryostat (10 μm) for immunohistochemistry.
Immunohistochemistry
Immunohistochemical analyses were performed as described previously (Colombo et al. 2004 ). Briefly, frozen or paraffin sections were boiled in 10 mM sodium citrate, pH 6.0 and blocked in 10% normal goat serum (NGS) and 0.2% Triton-X-100 for 1 h at room temperature. Incubation with primary antibodies was performed at 4°C overnight. Secondary antibodies were applied to sections for 2 h at room temperature. The primary antibodies utilized were as follows: rabbit anti-Tbr2 (1:200, Chemicon), chicken anti-GFP (1:500, Invitrogen), rat anti-BrdU (1:200, Biorad), anti-KI67 (1:100, Immunological Science), anti-Satb2 (1:200, AbCam), anti-Tle4 (1:100, Santa Cruz), Tbr1 (1:100, Abcam). Secondary antibodies were conjugates of Alexa Fluor 488, Alexa Fluor 594, and Alexa Fluor 647 (1:500) or biotin (1:200). DAPI (4',6'-diamidino-2-phenylindole) was used as nuclear counterstaining. Finally, slices were washed and mounted in Fluorescent Mounting Medium (Dako Cytomation).
Quantification and Statistical Analysis
Data collection and analysis were performed blind to genotype and the experimental conditions, data were collected and processed randomly. No statistical methods were used to predetermine sample sizes which were comparable to those reported in previous publications (Sessa et al. 2008 (Sessa et al. , 2010 and based on previous knowledge of the variability associated with the different experiments. At least three serial sections from three different animals for each genotype (biological replicats) were photographed using a Nikon Eclipse 600 fluorescent microscope. Each single experiment were repeted three times (technical replicats). Images were imported into Photoshop CS6. EGFP-only, marker-only, and/or doublepositive cells were overlaid manually by color-coded dots in new layers. The number of labeled cells (dots) was calculated using the record measurements of Photoshop CS3 and imported into Excel 2008. The total number of labeled cells per field per section was calculated across all brains. Results were expressed as the mean value of marker+ cells per field ± SEM and were tested for statistical significance by the one-tailed Student's t-test for paired differences with GraphPad Prism software. For the distribution of the marker+ cells in the cortical wall: the entire coronal section of the cortex was divided arbitrarily in four, six or eight bins (according to the developmental stage) and positive cells were counted per bin. Results were expressed as the percentage of the marker+ cells per bin on total marker+ cells per section and were tested for statistical significance by the one-tailed Student's t-test for paired differences with GraphPad Prism software.
Luciferase Reporter Assay
P19 cells (ATCC) were seeded in Minimum Essential Medium Eagle Alpha (Sigma-Aldrich) with 7.5% bovine calf serum and 2.5% fetal bovine serum. They were transfected 24 h after plating with 400 ng of each of the following constructs in different combinations: pT81 luciferase reporter plasmids, control plasmid pCAGiresGFP, pCAGArx-iresGFP, pCDNA3-Tle1, and 80 ng of pRL-TK-Renilla luciferase plasmid DNA (Promega) using Lipofectamine LTX with Plus Reagent (Life Technologies). Fortyeight hours post-transfection, cells were lysed and measurement of firefly and Renilla luciferase activity was performed using the Dual-Glo Luciferase Assay System (Promega) in a GloMax 20/20 Luminometer (Promega) according to the manufacturer's instructions. The firefly luciferase activity was normalized according to the corresponding Renilla luciferase activity, and the final LUC activity was reported as mean relative to pCAG-iresGFP/luciferase transfection. Each condition was repeated three times and each lysate was read three times independently. Primers used to clone the regions used as driver are reported in Table S3 .
NSC Cultures
Embryonic cortices were dissociated, fragmented in Hank's Balanced Salt Solution (HBSS, Life Technologies) with 1% Penicillin/Streptomycin (Sigma-Aldrich) and digested with papain (10 U/ml, Worthington Biochemical) and cysteine (1 mM, Sigma-Aldrich) in HBSS with 0.5 mM EDTA at 37°C. The obtained NSCs were routinely cultured in suspension as neurospheres.
Hippocampal Cultures
Primary neuronal cultures were prepared from the hippocampi of E17.5 mouse embryos. Briefly, hippocampi were dissected from mouse brains under a dissection microscope and treated with trypsin (Invitrogen) for 15 min at 37°C before triturating mechanically with fire-polished glass pipette to obtain a singlecell suspension. Approximately 7 × 10 4 cells were plated on coverslips coated with poly-L-lysine in 12-well plates and cultured in Neurobasal medium (Invitrogen) supplemented with B27 (Invitrogen) and glutamine (Sigma-Aldrich). Neurons were transfected 2 days after plating with CaCl 2 method and fixed for immunostaining 3 days after.
Results
Loss of Tbr2 Causes a Significant Alteration of Gene Expression in the Developing Cerebral Cortex
To investigate the impact of Tbr2 inactivation on the cortical neuronal gene expression program, we initially determined the differentially expressed genes between Tbr2 mutant and control cortices (Sessa et al. 2008) . Microarray-based transcriptome analysis was performed at E14.5 in order to detect early differences in expression profiling before the appearance of evident morphological changes in Tbr2 mutant brains (Sessa et al. 2008) . By this approach, we identified about 2200 differentially expressed genes which cluster in two groups of equally represented up and down-regulated genes in Tbr2 mutant compared with control cortices (Fig. 1A-C) . Interestingly, functional enrichment analysis revealed that the majority of them belong to GO categories mostly relevant for the nervous system development ( Figure S1A and Table S2A ). In particular, Tbr2 gene loss caused a reduced expression of critical molecular determinants in corticogenesis like Tbr1, Mef2, Bcl11b, Satb2 and Zfp238 (Fig. 1D ). Conversely, most upregulated genes showed that TBR2 is necessary to suppress genes that are not physiologically expressed in the cerebral cortex, but are present either in neighbor areas, such as the ventral telencephalon (i.e., Ebf1,2,3, Otx2 and Gbx2), or even in more distal regions as Tyrosine Hydroxylase (Th) (Fig. 1E ). Interestingly, all these genes presented a similar pattern of ectopic expression coinciding exactly with the SVZ region, the area where the INPs reside throughout the different stages of development (from E12.5 to E18.5) (Fig. 1F , Figure S1B and data not shown). Thus, these results suggest that upon Tbr2 loss, INPs undergo a process of molecular miss-specification rather than disappearance as they acquire the expression of genes encoding for transcription factors involved in the specification of alternative neuronal subtypes ( Fig. 1E ) (Kovach et al. 2013) . To confirm the ability of Tbr2 to suppress alternative cell fates, we electroporated E13.5 organotypic slices to force its expression in the ventral mesencephalon. Two days later, Tbr2 ectopic expression was found to strongly reduce TH protein that, conversely, was detectable in control (GFP electroporated) slices ( Figure S1C ). Altogether, these results confirmed the critical action of TBR2 in preventing the activation of spurious genes in INPs, including those coding for relevant developmental factors of different neuronal cell types, thus contributing to the correct specification of cortical INP cells.
TBR2 Binds and Regulates Different Classes of Developmental Related Genes
To determine the genome-wide TBR2 binding occupancy, we combined chromatin immunoprecipitation with massive deep sequencing (ChIP-seq). To preserve at best its biological significance, ChIP was performed on chromatin directly isolated from revealing the ectopic expression of the genes Ebf1, Ebf2, Ebf3 and Gbx2 in the Tbr2 mutant cortical SVZ domain. * = t-test, P < 0.05; *** = t-test, P < 0.001. ctx = cerebral cortex, bg = basal ganglia.
E14.5 dorsal telencephali using a validated TBR2 antibody. The subsequent sequence analysis uncovered >14.000 distinct DNA regions (false discovery rate, FDR, <5%) that were categorized in accordance with their position in the genome ( Fig. 2A) . The vast majority were mapped in distal intergenic regions (50%) or in known introns (31%) while less peaks were identified in regions considered to be gene promoters (<2 kb and 2-20 kb upstream of transcription start site TSS, 5% and 11% respectively) suggesting a regulation of gene expression mainly independent from proximal promoters. Remarkably, these (F-H) Luciferase assays showing that TBR2 directly represses (F), activates (H) or has no effect (H) on regulatory regions identified by ChIP-Seq and associated with genes relevant for cortex development. * = t-test, P < 0.05; *** = t-test, P < 0.001; N.S. = t-test, P > 0.05.
sequences shared a putative DNA-binding site for T-box proteins, confirming the accuracy of the identified binding events (MEME web-tool dataset, Fig. 2B ) (Sinha et al. 2000; Naiche et al. 2005) . A large fraction of peaks (36%) contains the T-box motifs whose distribution with respect of the closest TSS matches that of the whole peak profile (Fig. 2B ). To validate these results, independent ChIP-qPCR experiments were performed on candidate target regions confirming their robust enrichment in Tbr2-versus GFP-immunoprecipitated chromatin ( Figures S2A and D) . Antibody specificity was confirmed by the lack of qPCR amplification in TBR2 ChIP-qPCR experiments in Tbr2 KO tissues ( Figure S2A ). Tbr2 bound genomic regions were assigned to their nearest genes and interrogated by GO for their biological functions. Significantly, the most enriched biological processes included regulation of cell proliferation, cell migration and differentiation, all correlated with events occurring during cortical development ( Fig. 2C and Tables S2B-E) . We, then, stratified these genes for their expression pattern in E14.5 telencephalon according to available databases (www. genepaint.org; www.brain-map.org.). In this analysis, we identified putative Tbr2 target genes expressed exclusively in proliferative (VZ + SVZ) or differentiated (Cortical Plate, CP) regions or in both as well as genes with a more complex expression pattern ( Figure S2B ), suggesting a broad impact of TBR2 during corticogenesis.
To evaluate the impact of TBR2 in controlling the expression of its putative target genes, we crossed the ChIP-seq dataset (gene was called if the peak is <30 kb upstream or <1 kb downstream from the TSS) with the genes exhibiting a deregulated expression in Tbr2 mutants (Fig. 2E) . From this analysis, we obtained a list of 175 putative direct targets that were upregulated in Tbr2 deficient cortex and thus possibly repressed by TBR2, and 267 that could be directly activated (Fig. 2E , Table S1B ). Notably, the ChIP peaks related to these genes presented a consistent shift towards intronic regions in their distribution compared with the total peak distribution ( Figure S2E ). To experimentally test whether these genes were directly regulated by TBR2, we cloned different regulatory sequences of the selected misregulated genes previously validated by ChIP-qPCR and then assessed the direct transcriptional ability of TBR2 using promoter luciferase report assays ( Fig. 2F-H and Figure S2C ). Interestingly, TBR2 was able to activate Reelin, Fezf2 and Satb2 regulatory regions while repressing those associated with the Gadd45g and Hes5 genes (Fig. 2F, G, Figure S2C ). However, regulatory regions of other candidate genes were found to be insensitive to TBR2 (Fig. 2H , Figure S2C ). These negative findings might implicate the lack of the necessary cofactors or the appropriate chromatin architecture to enable the TBR2 function in P19 cells, or alternatively, the ancillary role of TBR2 in regulating the expression of some of its target genes. Certainly, these results might provide an explanation for the seemingly low grade of intersection between the ChIP-Seq and expression profile datasets (Fig. 2E ).
NEUROG2 Shares with TBR2 a Large Fraction of Binding Sites Along the Genome
We then explored the possibility that TBR2 can act synergistically with other transcription factors on some of its target genes. On this view, Neurogenin-2 (Neurog2) is a plausible candidate since it is a key determinant of the cortical excitatory neuronal lineage, promotes INP differentiation and exhibits a highly overlapping expression pattern with Tbr2 in the developing cortex (Fode et al. 2000; Noctor et al. 2004; Sessa et al. 2008; Kovach et al. 2013 ). Thus, we performed ChIP-Seq for NEUROG2 on E14.5 dorsal telencephali using an anti-NEUROG2 specific antibody identifying 2640 distinct genomic peaks located mainly in intergenic (48%) and intronic (30%) regions (Fig. 3A) . We were able to identify from this dataset a consensus for the E-box, the DNA sequence recognized by bHLH factors including Neurogenins (Bertrand et al. 2002) present in the 36% of the peaks which showed the same distribution with respect to TSS of the total set (Fig. 3B) . Intriguingly, a T-box consensus domain was identified in the same sequences suggesting the possibility that these regions could be bound by both factors together (Fig. 3B) . The results were verified by independent ChIP experiments confirming the enrichment in NEUROG2 compared with GFP (control) immunoprecipitated chromatin ( Figure S3A ). The 1534 genes identified as NEUROG2 targets included genes previously showed to be authentic NEUROG2 downstream effectors (e.g. Neurod1 and Rnd2) (Huang et al. 2000; Heng et al. 2008 ) ( Figure S3A ) and classified in GO categories closely related with neurogenesis ( Fig. 3C and Tables S2F-I).
The comparison between the genomic regions identified in Tbr2 and Neurog2 ChIP-Seq analyses revealed that the vast majority of the Neurog2 associated sequences overlaps with TBR2 bound regions ( Fig. 3D and Table S1C ). This finding was confirmed by independent ChIP assays performed on shared regions randomly chosen from the overlay of the datasets (Fig. 3E) . In TBR2/NEUROG2 common peaks we found high occurrence of both E-and T-box motifs ( Figure S3B ). Of note, the peaks containing both E-and T-boxes have a tendency to localize closer to the TSS respect to the total common regions ( Figure S3B ). These results prompted us to test for a possible interaction between NEUROG2 and TBR2 at protein level. Interestingly, NEUROG2 was detected in the TBR2 immunoprecipitated fraction of E14.5 cortical extracts (Fig. 3F) . These data suggest that the two proteins can assemble in the same complex, although do not necessary indicate their functional cooperation on gene regulation. To answer to this last issue, we selected regions upstream to Sox11 and Neurod4 (Fig. 3G and Figure S3B , respectively) where common peaks in Tbr2 and Neurog2 datasets were identified, and verified the individual binding of each of the two TFs by independent ChIP experiments ( Fig. 3H and Figure S3C ). Subsequently, the two regions were cloned upstream to a minimal promoter for luciferase transcriptional assays ( Fig. 3I and Figure S3D ). For the Sox11 enhancer, the action of either Tbr2 or Neurog2 alone triggered a 4-5 fold activation, while the two TFs together burst the expression to 14-fold over the basal level, thus demonstrating a strong positive synergic activity (Fig. 3I) . However, the effect of cooperation between the two TFs was different for the Neurod4 enhancer ( Figure S3D ). In this case, Tbr2 did not elicit any effect alone, but was sufficient to counteract the strong activation mediated by Neurog2 ( Figure S3E ). Interestingly, both targets are negatively regulated in Tbr2 mutant cortices (Fig. 3J and Figure S3G) . A similar finding was obtained when the Neurod1 promoter, containing both TBR2 and NEUROG2 bound regions, was tested ( Figure S3H-K) . In fact, the significant activation of the reporter gene by NEUROG2 resulted almost completely abolished by TBR2 coexpression ( Figure S3I ). This result is consistent with the increase expression level of NeuroD1 in Tbr2 mutant cortices ( Figure S3L ). Taken together, these data revealed a conserved functional cooperation of TBR2 and NEUROG2 on multiple target genes where their specific role might be synergic or opposite depending by the gene locus. Endogenous immunoprecipitation using anti-Tbr2 antibody (or anti-GFP as control) performed on E14.5 dorsal forebrain protein extracts reveals that TBR2 and NEUROG2 are in the same physical complex. (G) Visualization of Tbr2 (blue track) and Neurog2 (orange track) ChIP-seq peaks in Sox11 genomic locus. (H) qPCR analysis on independent Tbr2 and Neurog2 ChIP experiments for the region containing Tbr2 and Neurog2 overlapping peaks near to Sox11 gene. ORF is negative control region. Quantification in triplicate from at least two immunoprecipitation experiments. Mean ± SEM (I) Luciferase assay using the same region (Sox11 Enh, 1270 bp) tested in H using Tbr2, Neurog2 and the two TFs together. E-box (as E) and T-boxes (as T) sequences are indicated in the luciferase expressing vector. (J) Expression data obtained by RT-qPCR assays of Sox11 in control and Tbr2 mutant cortices. MP = minimal promoter. * = t-test, P < 0.05; *** = t-test, P < 0.001.
TBR2 Synergizes with NEUROG2 to Control Radial Migration by Modulating Rnd2 Expression
One crucial process during cerebral cortex formation is the timely radial migration of newly generated postmitotic neurons in the outward direction towards their final location (Ayala et al. 2007 ). Considering that a number of genes with a role in cell motility are apparently regulated by TBR2 (Fig. 2C and Table S2C ), we asked whether TBR2 has a function in modulating radial migration. In line with this possibility, Tbr2 gene expression is found higher in neural progenitors settled in the SVZ while rapidly decreases once they initiate radial migration (Noctor et al. 2004 ). To investigate this issue, we developed two different approaches to ectopically express Tbr2 exclusively in migrating neuron precursors, while leaving unperturbed the RGCs (Sessa et al. 2008) . First, in utero electroporations were conducted (Saito 2006 ) with a construct in which Tbr2 and/or GFP expression was driven by the Neurod1 promoter specifically in postmitotic neurons (Miyoshi and Fishell 2012) (Fig. 4A) . Two days after surgery, GFP + electroporated (control) cells were found scattered between the IZ (reflecting the endogenous Neurod1 expression) (Hevner et al. 2006 ) and the cortical plate, while Tbr2 overexpressing cells remained abnormally stacked within the IZ (Fig. 4A) . Notably, 5 days after electroporation control cells were correctly located in the most superficial layers of the cortical plate, while the Tbr2 overexpressing cells were spread throughout the cortical wall, thus indicating a delayed and defective radial migration pattern (Fig. 4A ). In the second approach, we employed a tamoxifen inducible construct for the timely activation of Tbr2 expression after in utero electroporation ( Figure S4A ). We found that the administration of 4-OHT at E14.5, 24 h after plasmid in vivo delivery, enabled to evaluate the Tbr2 overexpression in different subsets of cells according to their position at the time of the electroporation (e.g. apical region vs. basal) ( Figure S4A) . Notably, the block of migration resulting from Tbr2 overexpression was also evident in this experimental system, with ectopic masses of cells stacked in SVZ-IZ compared with the control ( Figure S4A ). In search for a molecular mechanism regulating this effect, we identified in the ChIP-Seq datasets candidate binding sites for TBR2 and NEUROG2 in the enhancer region of the Rnd2 gene coding for a small GTP-binding protein with a key role in radial migration (Fig. 4B, C) (Heng et al. 2008) . To explore whether and to what extent TBR2 and NEUROG2 control Rnd2 expression, we employed a luciferase reporter plasmid containing the Rnd2 enhancer/promoter element and verified its dependence by the two factors (Fig. 4D) . As already reported, NEUROG2 was more efficient than TBR2 to induce transcriptional activity (16-fold vs. 5-fold over basal level, Fig. 4D ) (Heng et al. 2008 ). However, equal coexpression of Neurog2 and Tbr2 led to a dramatic increase of the transcriptional activity as compared with each single factor (95-fold, Fig. 4D ), thus demonstrating a strong synergistic activity of the two TFs in regulating Rnd2. Surprisingly, transfection of an excess of Tbr2 in respect to Neurog2 caused a robust decrease in reporter activity as compared with the levels obtained using equimolar quantities of the two genes (Fig. 4D ). This finding suggested that a tight regulation in the relative expression levels of the two factors is crucial for correct radial migration of young neurons emerging from the germinal zones of the developing cortex. To corroborate this hypothesis in vivo, the two TFs were electroporated alone or together in the E13.5 developing cortex. Surprisingly, pNeurod1-Tbr2 overexpression leads to radial migration deficits accompanied with a robust Rnd2 expression decrease (Fig. 4A , E and F, Figure S4B ).
In contrast, concurrent overexpression of either Rnd2 or Neurog2 was sufficient to significantly rescue the block of cell migration caused by Tbr2 forced expression ( Fig. 4E and F) . In line with our in vivo data, genetic ablation of Tbr2 increases the expression of this gene ( Figure S4C, D) . Altogether, these data demonstrate that TBR2 and NEUROG2 cooperate to regulate radial neuronal migration. Despite the complex crossregulation established in the developing neurons, likely involving others cofactors to finely tune Rnd2 gene activation and maintenance, the TBR2/NEUROG2 interaction appears to be crucial for the correct transcriptional control of this small GTPbinding protein.
Tbr2 Negatively Regulates the RGC-specific Rapid Proliferation Rate
We noted that a good number of putative TBR2 targets are known to regulate cell division and cell-cycle progression ( Figure S1A ). We therefore asked whether Tbr2 could have a role in neuronal progenitor proliferation. In fact, while RGCs divide repeatedly with short cell-cycle time, the INPs generally go through one cell division before irreversibly exiting cellcycle. To investigate this issue, we overexpress Tbr2 in proliferating NSCs (Conti and Cattaneo 2010) isolated from E14.5 embryonic cortices and maintained in vitro as adherent cultures. Acute Tbr2 lentiviral transduction caused a robust decrease in NSC proliferation as scored by quantifying BrdU incorporation in cells after 2 h labeling (Fig. 5A, B) . We then evaluated the expression of putative TBR2 targets as identified in ChIP-Seq analysis involved in cell-cycle control such as the Notch signaling effector protein Hes5, microcephalin 1 (Mcph1), Cdk5 regulatory subunit associated protein 2 (Cdk5rap2), Btg2, Gadd45g and cyclin dependent kinase inhibitor (Cdkn1b) (Fig. 5C ). qPCR assays showed that Tbr2 overexpression caused a dramatic downregulation of Hes5, Mcph1 and Cdkrap2 that are closely associated with cell-cycle progression. In contrast, those factors associated with cell-cycle arrest like Btg2 and Cdkn1b were unchanged or moderately down-regulated (Fig. 5C ). These results suggest that Tbr2 can negatively modulate cell proliferation by controlling key molecules in this process. However, in vitro NSC proliferation dynamics differ significantly from the mitotic pattern observed in cortical INPs (Breunig et al. 2011) . Thus, we moved in vivo to determine the fraction of cells in active cell-cycle 24 h after Tbr2 electroporation ( Figure S5B ). Differently from previous findings on in vitro cultures, the fraction of GFP + cells that display Ki67 positivity remained unchanged upon Tbr2 overexpression ( Figures S5C, and S5D ).
To limit gene overexpression to the highly proliferative RGCs in the VZ, we examined the cells within 6 h after electroporation (Fig. 5D ). At this early time point, Tbr2 targeted cells already expressed the exogenous protein ( Figure S5A ) and exhibited both a lower BrdU incorporation (1 h pulse) and a reduction in the number of Ki67 positive cells compared with controls ( Fig. 5E-G) .
To better investigate the discrepancy with the already reported proliferative induction of SVZ cells (Sessa et al. 2008) , we analyzed gene expression exclusively in the electroporated cells by performing FACS-sorting of GFP+ cells followed by qPCR gene expression analysis 24 h after surgery (Fig. 5F ). Validating the system, Tbr2 was found highly expressed in the sorted Tbr2-iresGFP cell population while Pax6 and Sox2 resulted strongly down-regulated (Fig. 5H) , suggesting a shift from RGCs to INP genetic program as previously reported (Sessa et al. 2008) . We then assessed the expression of the cellcycle genes in the Tbr2 electroporated cells. As previously found in vitro, Hes5, Mcph1 and Cdk4rap2 were down-regulated (Fig. 5I) , together with the increase of cyclin G2 (Ccng2) (data not shown) accounting for a negative impact on proliferation kinetics. However, the downregulation of Btg2, Gadd45g and Cdkn1b might restrain to exit from cell-cycle. To expand this analysis we evaluated the expression of the same genes after and Sox2 was still retained (Fig. 5H) , while genes promoting cell-cycle such as Hes5, Cdk5rap2 and Cdkn1b were found upregulated ( Fig. 5I green bars) suggesting a scenario in which in the absence of Tbr2 the cells remained in a apical progenitor- Expression of cell-cycle related genes Hes5, Mcph1, Cdk5rap2, Btg2, Gadd45g and Cdkn1b by qPCR analysis upon Tbr2 gain or loss of function in vivo. * = t-test, P < 0.05; *** = t-test, P < 0.001; N.S. = t-test, P > 0.05.
like state. Altogether, these data define a cell type specific action of TBR2 on cell-cycle regulation. In fact, it counteracts cell proliferation in highly proliferating cells such as RGCs, as revealed on in vitro cultures of NSCs. However in less proliferating INPs, its action is permissive to cell-cycle progression, inhibiting the function of genes promoting cell-cycle arrest. These molecular findings provide a molecular understanding underlying the slow and limited proliferation behavior of the Tbr2 + INPs (Noctor et al. 2004 ).
TBR2 Represses Neuronal Polarity and Neurite Outgrowth
During development, Tbr2 expression vanishes out exactly when INPs differentiate into mature cortical neurons. We, thus, asked whether maintaining Tbr2 expression beyond INP stage could interfere with neuronal morphological maturation. Remarkably, in vivo Tbr2 overexpression in cortical neurons caused a significant reduction in dendritic complexity as compared with control GFP expressing neurons, thus indicating a possible role for Tbr2 in preventing INPs to acquire a mature neuronal morphology ( Figure S6A ). To better investigate this effect we employed primary cultures of mouse embryonic hippocampal neurons. Upon isolation and subsequent plating in the dish, these neurons initially lack any neurite, but with time they mature in vitro developing a complex dendritic tree (Bradke and Dotti 2000) . Two days in vitro (DIV) cultured hippocampal neurons were infected with GFP or Tbr2-GFP and the effects were tested 3 days afterwards on neurite development and branching ( Figure S6B ). Sholl analysis (Sholl 1953) showed that Tbr2 + neurons exhibited an evident simplified morphology with reduced neurite branching compared with GFP+ only expressing neurons ( Figure S6C ). In addition, we noticed that crucial regulators of neurite outgrowth were included TBR2 target gene dataset and could therefore mediate this effect. Thus, we performed qPCR expression profiling of some of these candidates in FACS-isolated cells from cortical tissue electroprorated with Tbr2-GFP after 48 h. Of note, we found that TBR2 was able to strongly repress the p21-activated kinases Pak1 and Pak3 (Hayashi et al. 2007; Nikolic 2008; Demyanenko et al. 2010) , Rac GTP exchange factors Tiam1 and Tiam2 (Ehler et al. 1997; Miyamoto et al. 2006; Shirazi Fard et al. 2010; Goto et al. 2011; Demarco et al. 2012 ) and the microtubule associate protein-2 Map2 (Harada et al. 2002) (Figure S6D ). The same genes were similarly repressed in the Tbr2 infected hippocampal neurons (data not shown). Conversely, Tbr2 acute loss-of-function caused a reciprocal gene expression alteration with a heightened expression of these factors ( Figure S6D , green bars). These findings suggest that TBR2 represses important determinants of neuronal polarity that promote axonal growth and dendritic complexity in developing cortical neurons, as for the case of the Tiam and PAK factors. Thus, the prevention of the neuronal morphological maturation of INPs represents a key role of TBR2 that together with its importance for resolution of RGC features are crucial for the maintenance of the correct cell shape of INPs while remaining in the SVZ domain.
TBR2 Interacts with JMJD3 for the Timely Activation of the Neuronal Specific Genes
Recent studies have revealed how the epigenetic control of gene transcription is pivotal to maintain the balance between RGC self-renewal and differentiation (Meaney and FergusonSmith 2010) . In particular, the repressive epigenetic mark H3K27me3 induced by the Polycomb Repressive Complex is critical for the widespread repression of regulatory genes responsible for neuronal cell lineage determination Lee et al. 2006) . We noticed that a significant fraction of the putative TBR2 binding domains were located into regulatory regions considerably enriched for the repressive histone mark H3K27me3 (Mohn et al. 2008) , belonging to genes normally expressed in the developing cortical plate, e.g. Tbr1, Cdh8, Cdh13, Camk2b and others ( Figure S7A and Table S1D ). Interestingly, by comparing the TBR2 binding sites and the H3K27me3 enriched sequences we found common DNA regions associated to genes important for cortical development, e.g. Slc17a6, Sox5, Bcl11b, Bhlhe22 ( Figure S7B and Table S1E ) (Ramos et al. 2013) . Considering that the enrichment in H3K27me3 histone mark was found in promoters of neural progenitors, their associated genes were predicted to be activated during neuronal maturation by active demethylation ( Figure S7C ). Thus, we sought to investigate whether the activation of these genes during in vivo neuronal differentiation was associated to specific H3K27me3 demethylation. For this aim, we isolated by FACS the GFP -and GFP + cell populations from E14.5 Tbr2-GFP mouse cortices, which corresponded to RGCs/early INPs and late INPs/neurons, respectively (Kwon and Hadjantonakis 2007; Sessa et al. 2008 ) ( Figure S7D ). As expected, GFP + cells showed a robust decrease in the cell progenitor markers Pax6 and Ccnd2, together with the upregulation of the neuronal differentiationassociated genes Dcx, Mef2c, Tbr1, NeuroD1, Sox5 and others ( Figure S7E ). We then assessed the respective H3K27me3 levels by ChIP assay within the TBR2 binding regions associated with these genes. Intriguingly, we found a consistent reduction of this epigenetic mark in the majority of these regions in the GFP + compared with the GFP -cell populations ( Figure S7F ). To independently confirm these data, we performed a comparison between E14.5 versus E18.5 cortices, reasoning that at late developmental stages there is a drastic loss of cortical neural progenitors and an enrichment in postmitotic neurons. Accordingly, we confirmed an upregulation of the genes of interests at E18.5 ( Figure S7G ) that was accompanied with the H3K27me3 demethylation on the associated regulatory regions in a large fraction of these genes ( Figure S7H ). Altogether, these data demonstrate that the majority of the TBR2 putative target genes transcriptionally upregulated during neuronal differentiation are subjected to H3K27 demethylation during cortical development.
It has been recently shown that T-box protein-dependent transcriptional activation can be mediated by JMJD3 and UTX demethylases during immune system differentiation (Miller et al. 2008 (Miller et al. , 2010 ). Thus we asked whether TBR2 can interact with histone demethylase(s) in the neural cells and thereby promote neuronal gene activation. While Utx is not expressed in the developing brain (data not shown), Jmjd3 transcripts were detected in virtually all the cell types of the developing cortex including the Tbr2 + progenitors (Fig. 6A-C) . Interestingly, we noticed that a fraction of the TBR2 binding regions were shared with those targeted by JMJD3 in NSCs (Estaras et al. 2012) and, among them, those associated with genes expressed in the cortical plate, e.g. Satb2, Sox5, Tle4, Hdac5 (Fig. 6D and Table S1F ). GO biological processes enriched in this intersection were consistent with cortical development (Fig. 6E and Table S2D ). Notably the overlapping regions between TBR2 and JMJD3 were distributed in the genome similarly to the whole TBR2 dataset while they differed from the entire set of JMJD3 targets that resulted more associated to gene promoters ( Fig. 6F ) (Estaras et al. 2012 ). Thus, we sought to test whether TBR2 and JMJD3 can interact physically and functionally. Remarkably, TBR2 and JMJD3 can be associated within the same protein complex as shown in coimmunoprecitipation experiments on NSC extracts (Fig. 6G) . To test any functional interaction between these two proteins, we compared the expression of candidate genes in proliferating NSCs overexpressing Tbr2, Jmjd3 or the two factors together (Fig. 6H) .
Remarkably, expression of neuronal-specific genes like Sox5, Tle4, Zfp238 and others resulted strongly upregulated only when both Tbr2 and Jmjd3 were coexpressed. (Fig. 6I ). Of note, this was not the case for either NSC specific genes Hes5 and Pax6 or the known JMJD3 target astroglial related gene S100b, which was activated only by the Jmjd3 overexpression (Fig. 6I) .
We then performed independent ChIP-qPCRs for TBR2 and Quantification in triplicate from at least two ChIP experiments. Mean ± SEM. * = t-test, P < 0.05; *** = t-test, P < 0.001; N.S. = t-test, P > 0.05. cc = corpus callosum.
JMJD3 on NSCs coexpressing both exogenous genes. These experiments revealed a robust enrichment of both proteins on the regulatory regions of the overexpressed genes (Fig. 6J) . However, when NSCs were infected with JMJD3 alone, its binding was not detectable on the TBR2 coregulated targets, while it was still maintained on the S100b gene locus (Fig. 6J) . Altogether, these results reveal that removing the H3K27me3 repressive mark through the combinatorial action of TBR2 and JMJD3 activates some critical determinants of the cortical neuronal differentiation.
To validate the relevance of this mechanism in vivo, we employed the in utero electroporation system to target the developing cortex with plasmids expressing Tbr2 and/or a negative form of Jmjd3 in which the catalytic JmjC domain is inactivated (Jmjd3-Mut) (Burgold et al. 2008) (Figure S8 ). Fortyeight hours after surgery, electroporated control cells were partially migrated along the cortical plate ( Figure S8A ), while the cells expressing Tbr2 and Jmjd3-Mut (alone or in combination) were arrested in the SVZ region ( Figures S8B, S8C and S8D ). We then FACS-sorted the GFP + cells from cortices electroporated with the different gene combinations and investigate the expression levels of the candidate genes by qPCR ( Figure S8E and S8F). Although misexpression of Tbr2 alone was sufficient to robustly up-regulate candidate neuronal specific genes ( Figure S8F , blue bars), coexpression with the Jmjd3-Mut strongly repressed the TBR2-mediated activation on the majority its target genes ( Figure S8F , green bars). These data suggests that TBR2 requires the catalytic activity of JMJD3 to de-repress a set of its specific targets. We then wondered whether full inactivation of Jmjd3 in mice would lead to defects in cerebral cortex development resembling those described for Tbr2 loss of function. Since Jmjd3 knock-out mice die at birth we therefore limited our analysis to embryonic stages (Satoh et al. 2010) . E18.5 Jmjd3 mutants exhibited a microcephalic phenotype with a significant thinner cortical wall (Fig. 7A) . As previously reported for Tbr2 gene inactivation (Arnold et al. 2008; Sessa et al. 2008) , Jmjd3 mutants exhibited a significant reduction in the SATB2 the cortical domains are presented in insets. ob = olfactory bulbs, hi = hippocampus. * = t-test, P < 0.05; *** = t-test, P < 0.001.
and TBR1
+
/TLE4
+ neuronal populations defining the upper and cortical layers, respectively ( Fig. 7B and data not shown). Likewise, gene expression pattern of additional markers of layer identity such as Sox5, Tle4 and Math2 revealed a similar reduced expression domain confirming the general loss of cortical neurons in Jmjd3 mutants (Fig. 7C ). This analysis confirms the critical role of JMJD3 in cortical development that might be related to its function in activating critical genes in neuronal differentiation in cooperation with TBR2. Again, both Tbr2 and Jmjd3 gene inactivation lead to a comparable reduction in cerebral cortex growth leading to microcephaly with comparable neuronal loss in both deep and superficial cortical layers. Altogether these data strongly suggest that TBR2 and JMJD3 act synergistically to promote neuronal differentiation, by acting together on a subset of their respective molecular targets. Mechanistically, TBR2 might direct JMJD3 on its target gene regulatory regions to erase the H3K27me3 repressive mark by active demethylase activity and thus by de-repressing the neuronal lineage specific genes maintained in a poised or bivalent state in neural progenitors (Mohn et al. 2008; Hirabayashi and Gotoh 2010) .
Discussion
In this study, we uncovered the molecular network regulated by Tbr2 during cortical development. This was obtained by combining transcriptome profiling of Tbr2 mutant cortices together with in vivo analysis of TBR2 binding sites at whole genome scale. Our results demonstrate that Tbr2 is a master regulator of INP identity by controlling an array of molecular pathways responsible for both INP progression along the glutammatergic lineage and blocking of alternative neural fates. In particular, we have defined the critical TBR2 target genes having an impact on the fundamental aspects of INPs such as cell-cycle profile, morphology, migration and glutammatergic lineage cell fate. Importantly, this study identified a genetic and an epigenetic cofactor with a major role in controlling TBR2 transcriptional activity. In fact, our data demonstrated that TBR2 can act as a molecular partner with NEUROG2 for transcriptional regulation during corticogenesis, not just as a NEUROG2 downstream effector as showed previously (Kovach et al. 2013) . We revealed a possible example of the TBR2/ NEUROG2 combinatorial action involved in the precise modulation of Rnd2, a gene with a fundamental role in cortical neural radial migration modulating RhoA signaling (Heng et al. 2008; Pacary et al. 2011 ). An unexpected complexity in the modulation of Rnd2 expression depending on the relative dosage of TBR2 and NEUROG2 has been highlighted. We privilege a model in which, equal levels of these two factors are able to sustain the highest Rnd2 expression that occurs in a very specific phase of INPs, coinciding with the initiation of their radial migration while exiting the SVZ. The absence of Tbr2 -probably scrambling the correct sequence of events occurring in glutammatergic development -promotes precocious radial migration, which dependents on high level of Rnd2 as shown herein ( Figure S5 ). Considering the high number of bound regions shared by TBR2 and NEUROG2, we predict that their combinatorial functions are likely operating on other important target genes (Fig. 3) . This scenario would explain why relatively few factors are regulating a wide array of cellular behaviors during cortical neuronal differentiation and it is in line with the fast dynamics of Neurogenin1/2 expression levels that can alter the relative ratio between NEUROG2 and TBR2 levels (Shimojo et al. 2008; Wilkinson et al. 2013 ). This combinatorial activity with different outputs, based on the two factor relative ratio, offers a fast and flexible mechanism for the fine control of the excitatory neuronal specification and migration in the developing cortex.
In this study, we also identified the histone demethylase JMJD3/KDM6B as the first epigenetic regulator directly associated with TBR2. This is of particular interest, since we provided first evidence that an active mechanism of H3K27me3 demethylation via the TBR2/JMJD3 protein cooperation is required for priming the activity of genes specific for the glutammatergic neuronal lineage determination and differentiation. Recently, it has been shown that JMJD3 can be recruited on both promoters and enhancers of genes relevant for neuronal and cortical development, and its activity is necessary for correct neuronal differentiation (Park et al. 2014 ). However, how JMJD3 is recruited to its correct targets in a cell-type and stage specific manner is largely unknown (Fig. 6A-C) . It has been showed that JMJD3 activity is essential for TGFβ-induced neuronal differentiation and its interaction with SMAD3 on a set of downstream promoters (Estaras et al. 2012) . Similarly, the tumor-suppressor P53 can interact with JMJD3 to modulate neurogenesis (Sola et al. 2011) . Finally, the JMJD3 binding to MLL1, a component of the trithorax group remodeling complex, leads to activation of specific target genes, including the neurogenic determinant Dlx2 during adult neurogenesis (De Santa et al. 2007; Park et al. 2014) . Moreover, the association between JMJD3 and the T-box factors is crucial for the correct T cell function (Miller 2008 (Miller , 2010 and endoderm differentiation (Kartikasari et al. 2013) , but this interaction has never been studied in cerebral cortex development where T-box factors have a significant role (Hevner et al. 2006) . Intriguingly, TBR2 is capable of recruiting JMJD3 thus spatially and temporally restricting its action on specific enhancers in the INP stage, a transient but critical step in cortical excitatory neuronal cell fate acquisition. This mechanism can account for the epigenetic silencing of a cohort of developmentally regulated genes during the neural progenitor stage, a chromatin modification to keep them silenced but ready for activation, to prime their full expression in postmitotic neurons. In addition, this molecular system might explain the aberrant expression of a subset of genes like Ebf1/2/3 and Gbx2 as caused by the uncontrolled action of JMJD3 on its non-cortical specific target genes. On this line, the TBR2/JMJD3 interaction would contribute to the simultaneous activation of the specific transcriptional program responsible for the neurogenic process as well as to the silencing of alternative gene expression networks.
Although from our data we cannot infer a specific mechanism of action for the TBR2/JMJD3 complex, Kartikasari et al. (2013) suggested that during definitive endoderm cell lineage differentiation the two proteins control gene expression by regulating the spatial reorganization of large chromatin domains to allow coherent enhancer-promoter interactions (Kartikasari et al. 2013 ). On the same line, during neuronal differentiation TBR2/JMJD3 might promote a specific chromatin architecture that would facilitate the activation of genetic determinants for this process. These findings provide support and validation in vivo of previous results performed exclusively in vitro about the correct neuronal cell differentiation regulated by epigenetic mechanisms (Mikkelsen et al. 2008; Mohn et al. 2008; Hirabayashi and Gotoh 2010) . Of note, a significant set of TBR2 binding regions does not appear to have an evident enriched H3K27me3 profile. These results depend from the fact that the available datasets have been extracted from heterogeneous experimental settings and different tissues/regions therefore limiting the informative value of this comparative analysis. Thus, future assessment of the H3K27 methylation dynamics over different stages in the developing cortex and its different cell types will provide the ground to match the epigenetic changes with the action of the developmental transcription factors involved in these processes.
Translating these results from mouse to human can be hard due to the different kinetics of the involved transcription factors during the different steps of corticogenesis in the two species. For instance, Pax6 and Tbr2 are rarely present in the same cells in mice, while they are largely coexpressed at in human OSVZ progenitors. Thus, while the downstream targets can differ in a species-specific manner, our results can help to explore the peculiarities that are crucial for cerebral cortex development and glutammatergic neuronal specification. In conclusion, this study defines Tbr2 as a critical regulator for INPs by controlling a large and complex genetic network responsible for multiple aspects of the biology of this particular class of neuronal progenitors.
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